Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 122

1.

CAL2 monoclonal antibody is a rapid and sensitive assay for the detection of calreticulin mutations in essential thrombocythemia patients.

Bonifacio M, Montemezzi R, Parisi A, De Matteis G, Bertorelle R, Scaffidi L, Candiotto C, Lippi G, Zamò A, Chilosi M, Pizzolo G, Scarpa A, Krampera M.

Ann Hematol. 2019 Jun 27. doi: 10.1007/s00277-019-03741-8. [Epub ahead of print]

PMID:
31250082
2.

Impact of 2016 WHO diagnosis of early and overt primary myelofibrosis on presentation and outcome of 232 patients treated with ruxolitinib.

Palandri F, Palumbo GA, Abruzzese E, Iurlo A, Polverelli N, Elli E, Bonifacio M, Bergamaschi M, Martino B, Tiribelli M, Benevolo G, Tieghi A, Sgherza N, Isidori A, Binotto G, Crugnola M, Heidel F, Cavazzini F, Bosi C, Auteri G, Cattaneo D, Foà R, Lemoli RM, Cuneo A, Krampera M, Bartoletti D, Cavo M, Vianelli N, Breccia M, Latagliata R.

Hematol Oncol. 2019 Apr 15. doi: 10.1002/hon.2619. [Epub ahead of print]

PMID:
30985017
3.

Is platelet gel safe enough for neutropenic patients?

Piccin A, Bacigalupo A, Zini G, Hamidieh AA, Bianchi M, Sica S, Valentini CG, Wolf D, Dazzi F, Fontanella F, Krampera M, Field S, Smith OP.

Transfus Apher Sci. 2019 Apr;58(2):190-191. doi: 10.1016/j.transci.2019.02.004. Epub 2019 Mar 19. No abstract available.

PMID:
30922679
4.

Extracellular Vesicles Mediate Mesenchymal Stromal Cell-Dependent Regulation of B Cell PI3K-AKT Signaling Pathway and Actin Cytoskeleton.

Adamo A, Brandi J, Caligola S, Delfino P, Bazzoni R, Carusone R, Cecconi D, Giugno R, Manfredi M, Robotti E, Marengo E, Bassi G, Takam Kamga P, Dal Collo G, Gatti A, Mercuri A, Arigoni M, Olivero M, Calogero RA, Krampera M.

Front Immunol. 2019 Mar 12;10:446. doi: 10.3389/fimmu.2019.00446. eCollection 2019.

5.

Role of mesenchymal stromal cell-derived extracellular vesicles in tumour microenvironment.

Adamo A, Dal Collo G, Bazzoni R, Krampera M.

Biochim Biophys Acta Rev Cancer. 2019 Jan;1871(1):192-198. doi: 10.1016/j.bbcan.2018.12.001. Epub 2018 Dec 30. Review.

6.

Inhibition of Notch Signaling Enhances Chemosensitivity in B-cell Precursor Acute Lymphoblastic Leukemia.

Takam Kamga P, Dal Collo G, Midolo M, Adamo A, Delfino P, Mercuri A, Cesaro S, Mimiola E, Bonifacio M, Andreini A, Chilosi M, Krampera M.

Cancer Res. 2019 Feb 1;79(3):639-649. doi: 10.1158/0008-5472.CAN-18-1617. Epub 2018 Dec 18.

PMID:
30563887
7.

Safety and efficacy of switching from branded to generic imatinib in chronic phase chronic myeloid leukemia patients treated in Italy.

Bonifacio M, Scaffidi L, Binotto G, Miggiano MC, Danini M, Minotto C, Griguolo D, Marin L, Frison L, D'Amore F, Basso M, Sartori R, Tinelli M, Stulle M, Fortuna S, Bonalumi A, Bertoldero G, De Biasi E, Ruggeri M, Semenzato G, Fanin R, Pizzolo G, Krampera M, Tiribelli M.

Leuk Res. 2018 Nov;74:75-79. doi: 10.1016/j.leukres.2018.09.018. Epub 2018 Oct 2.

PMID:
30308414
8.

Primary sphenoid lymphoma: Focus on imaging.

Facchinelli D, Boninsegna E, Barillari M, Mansueto G, Krampera M, Veneri D.

Tumori. 2018 Dec;104(6):NP42-NP45. doi: 10.1177/0300891618803501. Epub 2018 Oct 1.

PMID:
30270769
9.

MYC-related microRNAs signatures in non-Hodgkin B-cell lymphomas and their relationships with core cellular pathways.

Malpeli G, Barbi S, Tosadori G, Greco C, Zupo S, Pedron S, Brunelli M, Bertolaso A, Scupoli MT, Krampera M, Kamga PT, Croce CM, Calin GA, Scarpa A, Zamò A.

Oncotarget. 2018 Jul 3;9(51):29753-29771. doi: 10.18632/oncotarget.25707. eCollection 2018 Jul 3.

10.

MicroRNA signatures and Foxp3+ cell count correlate with relapse occurrence in follicular lymphoma.

Malpeli G, Barbi S, Greco C, Zupo S, Bertolaso A, Scupoli MT, Krampera M, Kamga PT, Croce CM, Scarpa A, Zamò A.

Oncotarget. 2018 Apr 13;9(28):19961-19979. doi: 10.18632/oncotarget.24987. eCollection 2018 Apr 13.

11.

Characterization of a new B-ALL cell line with constitutional defect of the Notch signaling pathway.

Kamga PT, Dal Collo G, Bassi G, Midolo M, Delledonne M, Chilosi M, Bonifacio M, Krampera M.

Oncotarget. 2018 Apr 6;9(26):18341-18350. doi: 10.18632/oncotarget.24836. eCollection 2018 Apr 6.

12.

Excellent outcomes of 2G-TKI therapy after imatinib failure in chronic phase CML patients.

Tiribelli M, Bonifacio M, Binotto G, Iurlo A, Cibien F, Maino E, Guella A, Festini G, Minotto C, De Biasi E, De Marchi F, Scaffidi L, Frison L, Bucelli C, Medeot M, Calistri E, Sancetta R, Stulle M, Orofino N, Krampera M, Gherlinzoni F, Semenzato G, Pizzolo G, Ambrosetti A, Fanin R.

Oncotarget. 2018 Feb 12;9(18):14219-14227. doi: 10.18632/oncotarget.24478. eCollection 2018 Mar 6.

13.

Effective control of acute myeloid leukaemia and acute lymphoblastic leukaemia progression by telomerase specific adoptive T-cell therapy.

Sandri S, De Sanctis F, Lamolinara A, Boschi F, Poffe O, Trovato R, Fiore A, Sartori S, Sbarbati A, Bondanza A, Cesaro S, Krampera M, Scupoli MT, Nishimura MI, Iezzi M, Sartoris S, Bronte V, Ugel S.

Oncotarget. 2017 May 23;8(50):86987-87001. doi: 10.18632/oncotarget.18115. eCollection 2017 Oct 20.

14.

Adipocytes sustain pancreatic cancer progression through a non-canonical WNT paracrine network inducing ROR2 nuclear shuttling.

Carbone C, Piro G, Gaianigo N, Ligorio F, Santoro R, Merz V, Simionato F, Zecchetto C, Falco G, Conti G, Kamga PT, Krampera M, Di Nicolantonio F, De Franceschi L, Scarpa A, Tortora G, Melisi D.

Int J Obes (Lond). 2018 Mar;42(3):334-343. doi: 10.1038/ijo.2017.285. Epub 2017 Nov 20.

15.

A new monoclonal antibody detects downregulation of protein tyrosine phosphatase receptor type γ in chronic myeloid leukemia patients.

Vezzalini M, Mafficini A, Tomasello L, Lorenzetto E, Moratti E, Fiorini Z, Holyoake TL, Pellicano F, Krampera M, Tecchio C, Yassin M, Al-Dewik N, Ismail MA, Al Sayab A, Monne M, Sorio C.

J Hematol Oncol. 2017 Jun 21;10(1):129. doi: 10.1186/s13045-017-0494-z.

16.

Mesenchymal stromal cells' role in tumor microenvironment: involvement of signaling pathways.

Nwabo Kamdje AH, Kamga PT, Simo RT, Vecchio L, Seke Etet PF, Muller JM, Bassi G, Lukong E, Goel RK, Amvene JM, Krampera M.

Cancer Biol Med. 2017 May;14(2):129-141. doi: 10.20892/j.issn.2095-3941.2016.0033.

17.

Developmental pathways associated with cancer metastasis: Notch, Wnt, and Hedgehog.

Nwabo Kamdje AH, Takam Kamga P, Tagne Simo R, Vecchio L, Seke Etet PF, Muller JM, Bassi G, Lukong E, Kumar Goel R, Mbo Amvene J, Krampera M.

Cancer Biol Med. 2017 May;14(2):109-120. doi: 10.20892/j.issn.2095-3941.2016.0032.

18.

Stem cells to restore insulin production and cure diabetes.

Sordi V, Pellegrini S, Krampera M, Marchetti P, Pessina A, Ciardelli G, Fadini G, Pintus C, Pantè G, Piemonti L.

Nutr Metab Cardiovasc Dis. 2017 Jul;27(7):583-600. doi: 10.1016/j.numecd.2017.02.004. Epub 2017 Feb 21. Review.

PMID:
28545927
19.

Observational retrospective study of vascular modulator changes during treatment in essential thrombocythemia.

Piccin A, Steurer M, Feistritzer C, Murphy C, Eakins E, Van Schilfgaarde M, Corvetta D, Di Pierro AM, Pusceddu I, Marcheselli L, Gambato R, Langes M, Veneri D, Perbellini O, Pacquola E, Gottardi M, Gherlinzoni F, Mega A, Tauber M, Mazzoleni G, Piva E, Plebani M, Krampera M, Gastl G.

Transl Res. 2017 Jun;184:21-34. doi: 10.1016/j.trsl.2017.02.001. Epub 2017 Feb 14.

PMID:
28259616
20.

Mesenchymal stromal cells (MSCs) induce ex vivo proliferation and erythroid commitment of cord blood haematopoietic stem cells (CB-CD34+ cells).

Perucca S, Di Palma A, Piccaluga PP, Gemelli C, Zoratti E, Bassi G, Giacopuzzi E, Lojacono A, Borsani G, Tagliafico E, Scupoli MT, Bernardi S, Zanaglio C, Cattina F, Cancelli V, Malagola M, Krampera M, Marini M, Almici C, Ferrari S, Russo D.

PLoS One. 2017 Feb 23;12(2):e0172430. doi: 10.1371/journal.pone.0172430. eCollection 2017.

21.

Identification of microRNAs implicated in the late differentiation stages of normal B cells suggests a central role for miRNA targets ZEB1 and TP53.

Malpeli G, Barbi S, Zupo S, Tosadori G, Scardoni G, Bertolaso A, Sartoris S, Ugel S, Vicentini C, Fassan M, Adamo A, Krampera M, Scupoli MT, Croce CM, Scarpa A.

Oncotarget. 2017 Feb 14;8(7):11809-11826. doi: 10.18632/oncotarget.14683.

22.

In Vivo Effects of Mesenchymal Stromal Cells in Two Patients With Severe Acute Respiratory Distress Syndrome.

Simonson OE, Mougiakakos D, Heldring N, Bassi G, Johansson HJ, Dalén M, Jitschin R, Rodin S, Corbascio M, El Andaloussi S, Wiklander OP, Nordin JZ, Skog J, Romain C, Koestler T, Hellgren-Johansson L, Schiller P, Joachimsson PO, Hägglund H, Mattsson M, Lehtiö J, Faridani OR, Sandberg R, Korsgren O, Krampera M, Weiss DJ, Grinnemo KH, Le Blanc K.

Stem Cells Transl Med. 2016 Jun;5(6):845. doi: 10.5966/sctm.2015-0021erratum. No abstract available.

23.

Differential and transferable modulatory effects of mesenchymal stromal cell-derived extracellular vesicles on T, B and NK cell functions.

Di Trapani M, Bassi G, Midolo M, Gatti A, Kamga PT, Cassaro A, Carusone R, Adamo A, Krampera M.

Sci Rep. 2016 Apr 13;6:24120. doi: 10.1038/srep24120.

24.

Notch signalling drives bone marrow stromal cell-mediated chemoresistance in acute myeloid leukemia.

Takam Kamga P, Bassi G, Cassaro A, Midolo M, Di Trapani M, Gatti A, Carusone R, Resci F, Perbellini O, Gottardi M, Bonifacio M, Nwabo Kamdje AH, Ambrosetti A, Krampera M.

Oncotarget. 2016 Apr 19;7(16):21713-27. doi: 10.18632/oncotarget.7964.

25.

International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials.

Galipeau J, Krampera M, Barrett J, Dazzi F, Deans RJ, DeBruijn J, Dominici M, Fibbe WE, Gee AP, Gimble JM, Hematti P, Koh MB, LeBlanc K, Martin I, McNiece IK, Mendicino M, Oh S, Ortiz L, Phinney DG, Planat V, Shi Y, Stroncek DF, Viswanathan S, Weiss DJ, Sensebe L.

Cytotherapy. 2016 Feb;18(2):151-9. doi: 10.1016/j.jcyt.2015.11.008. Epub 2015 Dec 23.

26.

Meninges harbor cells expressing neural precursor markers during development and adulthood.

Bifari F, Berton V, Pino A, Kusalo M, Malpeli G, Di Chio M, Bersan E, Amato E, Scarpa A, Krampera M, Fumagalli G, Decimo I.

Front Cell Neurosci. 2015 Oct 2;9:383. doi: 10.3389/fncel.2015.00383. eCollection 2015.

27.

In Vivo Effects of Mesenchymal Stromal Cells in Two Patients With Severe Acute Respiratory Distress Syndrome.

Simonson OE, Mougiakakos D, Heldring N, Bassi G, Johansson HJ, Dalén M, Jitschin R, Rodin S, Corbascio M, El Andaloussi S, Wiklander OP, Nordin JZ, Skog J, Romain C, Koestler T, Hellgren-Johansson L, Schiller P, Joachimsson PO, Hägglund H, Mattsson M, Lehtiö J, Faridani OR, Sandberg R, Korsgren O, Krampera M, Weiss DJ, Grinnemo KH, Le Blanc K.

Stem Cells Transl Med. 2015 Oct;4(10):1199-213. doi: 10.5966/sctm.2015-0021. Epub 2015 Aug 18. Erratum in: Stem Cells Transl Med. 2016 Jun;5(6):845.

28.

Imatinib-treated chronic myeloid leukemia patients with discordant response between cytogenetic and molecular tests at 3 and 6 month time-points have a reduced probability of subsequent optimal response.

Bonifacio M, Binotto G, Maino E, Calistri E, Marin L, Scaffidi L, Frison L, De Marchi F, Krampera M, Semenzato G, Fanin R, Ambrosetti A, Tiribelli M; Gruppo Triveneto LMC.

Haematologica. 2015 Aug;100(8):e299-301. doi: 10.3324/haematol.2015.124685. Epub 2015 Mar 27. No abstract available.

29.

Injection molded polymeric micropatterns for bone regeneration study.

Zanchetta E, Guidi E, Della Giustina G, Sorgato M, Krampera M, Bassi G, Di Liddo R, Lucchetta G, Conconi MT, Brusatin G.

ACS Appl Mater Interfaces. 2015 Apr 8;7(13):7273-81. doi: 10.1021/acsami.5b00481. Epub 2015 Mar 24.

PMID:
25756304
30.

Epithelial-to-mesenchymal transition (EMT) induced by inflammatory priming elicits mesenchymal stromal cell-like immune-modulatory properties in cancer cells.

Ricciardi M, Zanotto M, Malpeli G, Bassi G, Perbellini O, Chilosi M, Bifari F, Krampera M.

Br J Cancer. 2015 Mar 17;112(6):1067-75. doi: 10.1038/bjc.2015.29.

31.

The challenge of defining mesenchymal stromal cell potency assays and their potential use as release criteria.

Galipeau J, Krampera M.

Cytotherapy. 2015 Feb;17(2):125-7. doi: 10.1016/j.jcyt.2014.12.008. No abstract available.

PMID:
25593076
32.

Role of blood cells dynamism on hemostatic complications in low-risk patients with essential thrombocythemia.

Piccin A, Steurer M, Mitterer M, Blöchl EM, Marcheselli L, Pusceddu I, Marabese A, Bertozzi I, Corvetta D, Randi ML, Elli E, Pogliani EM, Veneri D, Perbellini O, Krampera M, Pacquola E, Gottardi M, Tiribelli M, Guella A, Innella B, Vivaldi P, De Biasi E, Sancetta R, Rocconi R, Bassan R, Gherlinzoni F, Pizzolo G, Gastl G, Cortelazzo S.

Intern Emerg Med. 2015 Jun;10(4):451-60. doi: 10.1007/s11739-015-1186-8. Epub 2015 Jan 14.

PMID:
25585678
33.

New targeted therapies for breast cancer: A focus on tumor microenvironmental signals and chemoresistant breast cancers.

Nwabo Kamdje AH, Seke Etet PF, Vecchio L, Tagne RS, Amvene JM, Muller JM, Krampera M, Lukong KE.

World J Clin Cases. 2014 Dec 16;2(12):769-86. doi: 10.12998/wjcc.v2.i12.769. Review.

34.

Immunophenotypic analysis of hematopoiesis in patients suffering from Shwachman-Bodian-Diamond Syndrome.

Mercuri A, Cannata E, Perbellini O, Cugno C, Balter R, Zaccaron A, Tridello G, Pizzolo G, De Bortoli M, Krampera M, Cipolli M, Cesaro S.

Eur J Haematol. 2015 Oct;95(4):308-15. doi: 10.1111/ejh.12490. Epub 2015 Feb 10.

PMID:
25402872
35.

Effects of a ceramic biomaterial on immune modulatory properties and differentiation potential of human mesenchymal stromal cells of different origin.

Bassi G, Guilloton F, Menard C, Di Trapani M, Deschaseaux F, Sensebé L, Schrezenmeier H, Giordano R, Bourin P, Dominici M, Tarte K, Krampera M.

Tissue Eng Part A. 2015 Feb;21(3-4):767-81. doi: 10.1089/ten.TEA.2014.0269. Epub 2014 Dec 11.

36.

Signaling pathways in breast cancer: therapeutic targeting of the microenvironment.

Nwabo Kamdje AH, Seke Etet PF, Vecchio L, Muller JM, Krampera M, Lukong KE.

Cell Signal. 2014 Dec;26(12):2843-56. doi: 10.1016/j.cellsig.2014.07.034. Epub 2014 Aug 3. Review.

PMID:
25093804
37.

Immune regulatory properties of CD117(pos) amniotic fluid stem cells vary according to gestational age.

Di Trapani M, Bassi G, Fontana E, Giacomello L, Pozzobon M, Guillot PV, De Coppi P, Krampera M.

Stem Cells Dev. 2015 Jan 1;24(1):132-43. doi: 10.1089/scd.2014.0234.

38.

Mesenchymal stem cell biodistribution, migration, and homing in vivo.

Zhao W, Phinney DG, Bonnet D, Dominici M, Krampera M.

Stem Cells Int. 2014;2014:292109. doi: 10.1155/2014/292109. Epub 2014 Mar 11. No abstract available.

39.

MSCs: science and trials.

Phinney DG, Galipeau J, Krampera M, Martin I, Shi Y, Sensebe L.

Nat Med. 2013 Jul;19(7):812. doi: 10.1038/nm.3220. No abstract available.

PMID:
23836216
40.

Comparative study of immune regulatory properties of stem cells derived from different tissues.

Di Trapani M, Bassi G, Ricciardi M, Fontana E, Bifari F, Pacelli L, Giacomello L, Pozzobon M, Féron F, De Coppi P, Anversa P, Fumagalli G, Decimo I, Menard C, Tarte K, Krampera M.

Stem Cells Dev. 2013 Nov 15;22(22):2990-3002. doi: 10.1089/scd.2013.0204. Epub 2013 Aug 9.

41.

Importance of epigenetic changes in cancer etiology, pathogenesis, clinical profiling, and treatment: what can be learned from hematologic malignancies?

Vecchio L, Seke Etet PF, Kipanyula MJ, Krampera M, Nwabo Kamdje AH.

Biochim Biophys Acta. 2013 Aug;1836(1):90-104. doi: 10.1016/j.bbcan.2013.04.001. Epub 2013 Apr 17. Review.

PMID:
23603458
42.

Immunological characterization of multipotent mesenchymal stromal cells--The International Society for Cellular Therapy (ISCT) working proposal.

Krampera M, Galipeau J, Shi Y, Tarte K, Sensebe L; MSC Committee of the International Society for Cellular Therapy (ISCT).

Cytotherapy. 2013 Sep;15(9):1054-61. doi: 10.1016/j.jcyt.2013.02.010. Epub 2013 Apr 17.

43.

The TNF-family cytokine TL1A inhibits proliferation of human activated B cells.

Cavallini C, Lovato O, Bertolaso A, Pacelli L, Zoratti E, Zanolin E, Krampera M, Zamò A, Tecchio C, Cassatella MA, Pizzolo G, Scupoli MT.

PLoS One. 2013;8(4):e60136. doi: 10.1371/journal.pone.0060136. Epub 2013 Apr 2.

44.

Quantitative fluorescence in situ hybridization on paraffin embedded tissue.

Ricciardi M, Krampera M, Chilosi M.

Methods Mol Biol. 2013;976:167-73. doi: 10.1007/978-1-62703-317-6_13.

PMID:
23400442
45.

Clinical-grade mesenchymal stromal cells produced under various good manufacturing practice processes differ in their immunomodulatory properties: standardization of immune quality controls.

Menard C, Pacelli L, Bassi G, Dulong J, Bifari F, Bezier I, Zanoncello J, Ricciardi M, Latour M, Bourin P, Schrezenmeier H, Sensebé L, Tarte K, Krampera M.

Stem Cells Dev. 2013 Jun 15;22(12):1789-801. doi: 10.1089/scd.2012.0594. Epub 2013 Feb 25.

46.

VR09 cell line: an EBV-positive lymphoblastoid cell line with in vivo characteristics of diffuse large B cell lymphoma of activated B-cell type.

Nichele I, Zamò A, Bertolaso A, Bifari F, Tinelli M, Franchini M, Stradoni R, Aprili F, Pizzolo G, Krampera M.

PLoS One. 2012;7(12):e52811. doi: 10.1371/journal.pone.0052811. Epub 2012 Dec 21.

47.

Normal hematopoiesis and hematologic malignancies: role of canonical Wnt signaling pathway and stromal microenvironment.

Seke Etet PF, Vecchio L, Bogne Kamga P, Nchiwan Nukenine E, Krampera M, Nwabo Kamdje AH.

Biochim Biophys Acta. 2013 Jan;1835(1):1-10. doi: 10.1016/j.bbcan.2012.08.002. Epub 2012 Sep 5. Review.

PMID:
22982245
48.

Role of stromal cell-mediated Notch signaling in CLL resistance to chemotherapy.

Nwabo Kamdje AH, Bassi G, Pacelli L, Malpeli G, Amati E, Nichele I, Pizzolo G, Krampera M.

Blood Cancer J. 2012 May;2(5):e73. doi: 10.1038/bcj.2012.17. Epub 2012 May 25.

49.

Adipose-derived stromal cells (ASCs).

Bassi G, Pacelli L, Carusone R, Zanoncello J, Krampera M.

Transfus Apher Sci. 2012 Oct;47(2):193-8. doi: 10.1016/j.transci.2012.06.004. Epub 2012 Jul 19. Review.

PMID:
22818214
50.

Comparison of epithelial differentiation and immune regulatory properties of mesenchymal stromal cells derived from human lung and bone marrow.

Ricciardi M, Malpeli G, Bifari F, Bassi G, Pacelli L, Nwabo Kamdje AH, Chilosi M, Krampera M.

PLoS One. 2012;7(5):e35639. doi: 10.1371/journal.pone.0035639. Epub 2012 May 2.

Supplemental Content

Loading ...
Support Center